Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling

International Journal of Cancer

Volumn 119, Issue 10, 2006, Pages 2467-2475

  Shi, Wei ^a,b   Bastianutto, Carlo ^a,b   Li, Anna ^c   Perez Ordonez, Bayardo ^a,b   Ng, Raymond ^d   Chow, Kan Yan ^e   Zhang, Wendy ^a   Jurisica, Igor ^a,b,f   Lo, Kwok Wai ^g   Bayley, Andrew ^a,b   Kim, John ^a,b   O'Sullivan, Brian ^a,b   Siu, Lillian ^a,b   Chen, Eric ^a,b   Liu, Fei Fei ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Scarborough Centenary Hospital   (Canada)

^e William Osler Health Center   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

catenin; Apoptosis; Gene expression profiling; Integrin signaling; Nasopharyngeal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SURVIVIN; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LYMPHOID HYPERPLASIA; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA HYBRIDIZATION; RNA INTERFERENCE; TUMOR BIOPSY;

APOPTOSIS; BETA CATENIN; CARCINOMA; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MICROTUBULE-ASSOCIATED PROTEINS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; NF-KAPPA B P52 SUBUNIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; WNT PROTEINS;

EID: 33749628166     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22107     Document Type: Article

References (46)

1. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
2. Xie L, Xu L, He Z, Zhou W, Wang L, Zhang L, Lan K, Ren C, Liu W, Yao K. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array. J Cancer Res Clin Oncol 2000;126:400-6.
3. Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000;67:923-36.
4. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, Zhou M, Zhu S, Zhou J, Qian J, Lu H, He X et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 2003;38:80-90.
5. Sriuranpong V, Mutirangura A, Gillespie JW, Patel V, Amornphimoltham P, Molinolo AA, Kerekhanjanarong V, Supanakorn S, Supiyaphun P, Rangdaeng S, Voravud N, Gutkind JS. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 2004;10:4944-58.
6. Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu FF. Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res 2002;62:171-8.
7. Li JH, Shi W, Chia M, Sanchez-Sweatman O, Siatskas C, Huang D, Busson P, Klamut H, Yen WC, Richardson C, O'Sullivan B, Gullane P et al. Efficacy of targeted FasL in nasopharyngeal carcinoma. Mol Ther 2003;8:964-73.
8. Chia MC, Shi W, Li JH, Sanchez O, Strathdee CA, Huang D, Busson P, Klamut HJ, Liu FF. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy. Mol Ther 2004;9;804-17.
9. Yip KW, Li A, Li JH, Shi W, Chia MC, Rashid SA, Mocanu JD, Louie AV, Sanchez O, Huang D, Busson P, Yeh WC et al. Potential utility of BimS as a novel apoptotic therapeutic molecule. Mol Ther 2004;10:533-44.
10. Yip KW, Mocanu J, Au B, Sleep G, Huang D, Busson P, Bastianutto CFFL. The potential utility of Bcl-2 antisense therapy for nasopharyngeal cancer. Clin Cancer Res 2005;11:8131-44.
11. Yauk CL, Berndt ML, Williams A, Douglas GR. Comprehensive comparison of six microarray technologies. Nucleic Acids Res 2004;32:e124.
12. Shanmugaratnam K, Sobin L. Histological typing of upper respiratory tract tumors. Geneva: World Health Organization, 1978.
13. Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O'Sullivan B, Cummings BJ, Warde P, Liu FF. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 2002;94:1997-2006.
14. Sultan M, Wigle DA, Cumbaa CA, Maziarz M, Glasgow J, Tsao MS, Jurisica I. Binary tree-structured vector quantization approach to clustering and visualizing microarray data. Bioinformatics 2002;18 (Suppl 1): S111-S19.
15. Kohonen T. Self-organizing maps. New York: Springer, 1997.
16. Vesanto J. SOM-based data visualization methods. Intell Data Anal 1999;3:111-26.
17. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
18. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999;83:121-6.
19. Chang Y, Lee TC, Li JC, Lai TL, Chua HH, Chen CL, Doong SL, Chou CK, Sheen TS, Tsai CH. Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma. Head Neck 2005;27:873-82.
20. Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005;24:6525-32.
21. Fang WY, Liu TF, Xie WB, Yang XY, Wang S, Ren CP, Deng X, Liu QZ, Huang ZX, Li X, Ding YQ, Yao KT. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection. Acta Biochim Biophys Sin (Shanghai) 2005;37:541-6.
22. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio-the analysis and navigation of molecular networks. Bioinformatics 2003;19:2155-7.
23. Gielen SC, Kuhne LC, Ewing PC, Blok LJ, Burger CW. Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study. Endocr Relat Cancer 2005;12:1037-49.
24. Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, Zago MA. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ; signalling pathways. Br J Haematol 2005;130:516-26.
25. Bonome T, Lee J-Y, Park D-C, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res 2005;65:10602-12.
26. Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res 2005;65:10255-64.
27. Chang I-Y, Youn C-K, Kim H-B, Kim M-H, Cho H-J, Yoon Y, Lee Y-S, Chung M-H, You HJ. Oncogenic H-Ras up-regulates expression of Ku80 to protect cells from γ-ray irradiation in NIH3T3 cells. Cancer Res 2005;65:6811-19.
28. Salahshor S, Woodgett JR. The links between axin and carcinogenesis. J Clin Pathol 2005;58:225-36.
29. Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995;10:549-60.
30. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:473-87.
31. Stewart S, Dawson CW, Takada K, Curnow J, Moody CA, Sixbey JW, Young LS. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway. Proc Natl Acad Sci USA 2004;101:15730-5.
32. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
33. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003;201:204-12.
34. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-50.
35. Morrison JA, Klingelhutz AJ, Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J Virol 2003;77:12276-84.
36. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 2004;64:5251-60.
37. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the β-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2000;12:469-76.
38. Li J, Rao H, Burkin D, Kaufman SJ, Wu C. The muscle integrin binding protein (MIBP) interacts with α7β1 integrin and regulates cell adhesion and laminin matrix deposition. Dev Biol 2003;261:209-19.
39. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 2005;79:15430-42.
40. Kassis J, Maeda A, Teramoto N, Takada K, Wu C, Klein G, Wells A. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int J Cancer 2002;99:644-51.
41. Huang S, Stupack D, Liu A, Cheresh D, Nemerow GR. Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of α(v) integrins. Oncogene 2000;19:1915-23.
42. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-41.
43. Faqing T, Zhi H, Liqun Y, Min T, Huanhua G, Xiyun D, Ya C. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. Exp Oncol 2005;27:96-101.
44. Ai MD, Li LL, Zhao XR, Wu Y, Gong JP, Cao Y. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res 2005;15:777-84.
45. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res 2002;30:e48.
46. Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA, Altar CA. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 2004;138:173-88.